Banque Populaire Rives de Paris

Up&Charge specializes in automated induction charging stations that offer a wireless electric charging solution for electric vehicles. The company’s technology facilitates cable-free charging through an induction system, enabling users to recharge their vehicles without the need for supervision. These self-service charging stations operate around the clock, providing convenience and accessibility for electric vehicle owners. Additionally, Up&Charge's design preserves sidewalk space, making it a practical option for urban environments.

Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

Groupe Flo SA is a restaurant group based in Courbevoie, France, operating both owned and franchised establishments. As of May 2019, the company managed 178 restaurants, including 91 owned and 87 franchised, under well-known brands such as Hippopotamus, Maître Kanter's Taverne, and Bistro Romain. Additionally, it operates 25 breweries, including renowned venues like Le Vaudeville and La Coupole, with a mix of owned and franchised locations. The company also runs 13 concession restaurants located in prominent sites such as Disneyland Paris and Jardin des Plantes. Established in 1968, Groupe Flo has developed a diverse portfolio that caters to various dining preferences, both domestically and internationally.

Dianosic SAS, founded in 2017 and based in Strasbourg, France, specializes in developing advanced medical devices for Ear, Nose, and Throat (ENT) conditions. The company has created CAVI-T, an innovative intranasal balloon designed to stop spontaneous or postoperative bleeding through low-pressure compression, while also preventing biofilm formation and enhancing healing. Additionally, Dianosic is working on the Active Resorbable Intranasal Scaffold (ARIS), a groundbreaking treatment for chronic sinusitis and allergic rhinitis, which offers a long-lasting drug-eluting solution that can last from six to twelve months. This technology not only addresses patient compliance challenges but also presents opportunities for expanding treatment options in related areas such as chronic migraine and facial pain. Through its cutting-edge solutions, Dianosic aims to redefine standards of care in ENT healthcare.